Home
>
National Drug Code (NDC)
>
EXPECTUSS
EXPECTUSS - 23359-003-16 - (Carbetapentane Citrate, and Guaifenesin)
Drug Information of EXPECTUSS
| Product NDC: | 23359-003 |
| Proprietary Name: | EXPECTUSS |
| Non Proprietary Name: | Carbetapentane Citrate, and Guaifenesin |
| Active Ingredient(s): | 20; 75 mg/5mL; mg/5mL & nbsp; Carbetapentane Citrate, and Guaifenesin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | LIQUID |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of EXPECTUSS
| Product NDC: | 23359-003 |
| Labeler Name: | Centurion Labs, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20091130 |
Package Information of EXPECTUSS
| Package NDC: | 23359-003-16 |
| Package Description: | 473 mL in 1 BOTTLE (23359-003-16) |
NDC Information of EXPECTUSS
| NDC Code | 23359-003-16 |
| Proprietary Name | EXPECTUSS |
| Package Description | 473 mL in 1 BOTTLE (23359-003-16) |
| Product NDC | 23359-003 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Carbetapentane Citrate, and Guaifenesin |
| Dosage Form Name | LIQUID |
| Route Name | ORAL |
| Start Marketing Date | 20091130 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Centurion Labs, LLC |
| Substance Name | CARBETAPENTANE CITRATE; GUAIFENESIN |
| Strength Number | 20; 75 |
| Strength Unit | mg/5mL; mg/5mL |
| Pharmaceutical Classes |
